Viatris completes $36.50-per-share acquisition of Pacira BioSciences
The merger closed November 17, 2026, after Viatris's tender offer drew about 66.46% of outstanding shares, triggering a mandatory conversion rate change for Pacira's 2029 convertible notes.
SEC filing